Stryker (SYK) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.38% |
| Dec 31, 2025 | 11.83% |
| Sep 30, 2025 | 12.23% |
| Jun 30, 2025 | 12.67% |
| Mar 31, 2025 | -22.25% |
| Dec 31, 2024 | 25.44% |
| Sep 30, 2024 | 22.85% |
| Jun 30, 2024 | 6.63% |
| Mar 31, 2024 | -27.98% |
| Dec 31, 2023 | 9.17% |
| Sep 30, 2023 | 13.54% |
| Jun 30, 2023 | 1.73% |
| Mar 31, 2023 | 12.35% |
| Dec 31, 2022 | 10.58% |
| Sep 30, 2022 | 69.33% |
| Jun 30, 2022 | -5.75% |
| Mar 31, 2022 | 47.58% |
| Dec 31, 2021 | 9.04% |
| Sep 30, 2021 | 15.90% |
| Jun 30, 2021 | 15.29% |
| Mar 31, 2021 | 20.21% |
| Dec 31, 2020 | 9.73% |
| Sep 30, 2020 | 26.95% |
| Jun 30, 2020 | 12.07% |
| Mar 31, 2020 | 6.00% |
| Dec 31, 2019 | -2.81% |
| Sep 30, 2019 | -0.88% |
| Jun 30, 2019 | 2.27% |
| Mar 31, 2019 | 6.56% |
| Dec 31, 2018 | 7.69% |
| Sep 30, 2018 | -3.76% |
| Jun 30, 2018 | 9.75% |
| Mar 31, 2018 | -1.21% |
| Dec 31, 2017 | -2.06% |
| Sep 30, 2017 | -16.25% |
| Jun 30, 2017 | 5.03% |
| Mar 31, 2017 | 22.03% |
| Dec 31, 2016 | -1.77% |
| Sep 30, 2016 | -0.26% |
| Jun 30, 2016 | 28.78% |
| Mar 31, 2016 | -0.27% |
| Dec 31, 2015 | 7.85% |
| Sep 30, 2015 | -29.08% |
| Jun 30, 2015 | -0.02% |
| Mar 31, 2015 | 6.51% |
| Dec 31, 2014 | 4.37% |
| Sep 30, 2014 | 2.18% |
| Jun 30, 2014 | 15.47% |
| Mar 31, 2014 | -10.48% |